Pomalidomide and Low-Dose Dexamethasone Improves Health-Related Quality of Life and Prolongs Time to Worsening in Relapsed/Refractory Patients With Multiple Myeloma Enrolled in the MM-003 Randomized Phase III Trial
2015 ◽
Vol 15
(9)
◽
pp. 519-530
◽
Keyword(s):
Low Dose
◽